Literature DB >> 2360391

Perioperative intra-aortic balloon counterpulsation in cardiosurgery: a retrospective study.

E Lauwers, G Meese, H Adriaensen, B Amsel, M Van der Mast.   

Abstract

From January 1986 to March 1988 50 of 1366 patients (3.7%) undergoing cardiac surgery were treated with IABP support. The 50 patients ranged in age from 43 to 79 years (mean: 63.3 years). 88% of them underwent coronary artery bypass grafting, 6% of them mitral valve replacement and the other 6% a combined procedure. IABP was inserted preoperatively in 4 patients (8%) because of cardiogenic shock, and in 18 patients because of unstable angina (36%); intraoperatively as a help during weaning from cardiopulmonary bypass in 8 patients (16%); postoperatively because of hemodynamic deterioration in 20 patients (40%). The IABP was placed by femoral puncture in 39 patients (78%), by femoral cutdown in 6 patients (12%) and by transthoracic aortotomy in 5 patients (10%). All patients received daily infusions of heparin and broad spectrum antibiotics. The overall incidence of complications was 22%. There was no mortality due to IABP-related complications.

Entities:  

Mesh:

Year:  1990        PMID: 2360391

Source DB:  PubMed          Journal:  Acta Anaesthesiol Belg        ISSN: 0001-5164


  2 in total

1.  [Predictors of morbidity and mortality in patients undergoing intra-aortic counterpulsation balloon in cardiac surgery].

Authors:  Brahim Elahmadi; Youssef Motiaa; Abdedaim Elghadbane Hatim; Noureddine Atmani; Younes Moutakillah; Fouad Amal Wahid; Youssef Elbekkali; Mahdi Ait Houssa; Rachid Razine; Abdelatif Boulahya; Mohammed Drissi
Journal:  Pan Afr Med J       Date:  2015-08-28

2.  Clinical application of intra-aortic balloon pump in patients with cardiogenic shock during the perioperative period of cardiac surgery.

Authors:  Xuesong Jiang; Zhitao Zhu; Ming Ye; Yan Yan; Junbo Zheng; Qingqing Dai; Lianghe Wen; Huaiquan Wang; Shaofei Lou; Hongmei Ma; Pingwei Ma; Yunlong Li; Tuoyun Yang; Shu Zuo; Ye Tian
Journal:  Exp Ther Med       Date:  2017-03-02       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.